Typhoid Fever Vaccines Market
- 2026 年市場規模
- USD 558.6 Mn
- 2033 年預估規模
- USD 1,244.0 Mn
- 年複合成長率 CAGR
- 12.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Typhoid Fever Vaccines Market, By Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others), By Route of Administration (Oral, Parenteral), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
Typhoid fever is a bacterial infection caused by Salmonella typhi, which causes symptoms such as prolonged fever, headache, nausea, loss of appetite, and constipation or sometimes diarrhea. The bacterium usually enters the body through the mouth by the ingestion of contaminated food or water, penetrates the intestinal wall, and multiplies in lymphoid tissue. It then enters the bloodstream and causes bacteremia. People who drink contaminated water or eat food washed in contaminated water can develop typhoid fever. Typhoid fever is majorly caused in area with poor sanitation and lack of clean drinking water. Typhoid fever vaccines are the biological formulations, which provide immunity and protect an individual against typhoid fever.
Currently there are three typhoid vaccines recommended by the World Health organization (WHO) for use which include:
• Injectable typhoid conjugate vaccine (TCV), consisting of Vi polysaccharide antigen linked to tetanus toxoid protein licensed for children from 6 months of age and adults up to 45 years of age
• Injectable unconjugated polysaccharide vaccine based on the purified Vi antigen (known as Vi-PS vaccine) for persons aged two years and above, and
• Oral live attenuated Ty21a vaccine in capsule formulation for those over six years of age
Market Dynamics
Increasing initiatives by governments and various other organizations to increase awareness about typhoid vaccine and rising access of new vaccines is expected to drive the typhoid fever vaccines market growth during forecast period. For instance, in February 2019, Gavi, the Vaccine Alliance in partnership with WHO, Center for Disease Control and Prevention and Zimbabwe’s Ministry of Health launched a campaign to tackle typhoid outbreak in Zimbabwe. Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. The campaign aims to vaccinate 325,000 people in nine suburbs of Zimbabwe’s capital with new typhoid conjugate vaccine (TCV). At least 12.4 million children worldwide are categorized as ‘zero-dose’, living in missed communities that cannot access many essential services, including health care.
Key features of the study
• This report provides an in-depth analysis of the global typhoid fever vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global typhoid fever vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc. Shanghai Institute of Biological Products Co., Ltd., and Prokarium.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global typhoid fever vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global typhoid fever vaccines market
Market Segmentation
• By Vaccine Type
o Live Attenuated Vaccine
o Capsular Polysaccharide Vaccines
o Conjugate Vaccine
o Others
• By Route of Administration
o Oral
o Parenteral
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o GlaxoSmithKline Plc.
o Sanofi SA
o Bharat Biotech
o Bio-Med Pvt. Ltd.
o PT Bio Farma
o PaxVax, Inc.
o Shanghai Institute of Biological Products Co., Ltd.
o Prokarium
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Vaccine Type
Market Snapshot, By Route of Administration
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Novel Product Launch/Approval
o PEST Analysis
o Awareness Strategy
o Reimbursement Scenario
o Typhoid Fever Vaccines Shortage
o Clinical Trial Analysis
o Countries with High Number of Incidents of Snake Bites
o Market Entry Challenges
4. Global Typhoid Fever Vaccines Market, By Vaccine Type, 2026 – 2033, (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Live Attenuated Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Capsular Polysaccharide Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Conjugate Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
5. Global Typhoid Fever Vaccines Market, By Route of Administration, 2026 – 2033, (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Parental
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
6. Global Typhoid Fever Vaccines Market, By Region, 2026 – 2033, (US$ Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Million)
o North Africa
o Central Africa
o South Africa
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
GlaxoSmithKline Plc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Sanofi SA
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bharat Biotech
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bio-Med Pvt. Ltd.
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
PT Bio Farma
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
PaxVax, Inc.
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Shanghai Institute of Biological Products Co., Ltd.
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Prokarium
o Company Introduction
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
8. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們